Health
Even low-dose oral glucocorticoid use associated with increased CV risk – medwireNews
UK research has identified a “strong dose-dependent” association between oral glucocorticoid use and CVD risk among people with immune-mediated diseases, with an…
medwireNews: UK research has identified a strong dose-dependent association between oral glucocorticoid use and cardiovascular disease (CVD) risk among people with immune-mediated diseases, with an increased risk seen even at prednisolone-equivalent doses of less than 5 mg/day.
These results highlight the importance of prompt and regular monitoring of cardiovascular risk and use of primary prevention treatment at all glucocorticoid doses, write the researchers in PLOS Medicine.
Mar Pujades-Rodriguez…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?